➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Baxter
McKesson
Mallinckrodt
Express Scripts
Medtronic
Moodys

Last Updated: August 8, 2020

DrugPatentWatch Database Preview

Biogen Idec Company Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

US Patents for Biogen Idec

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Biogen Idec Inc PLEGRIDY peginterferon beta-1a INJECTABLE;INJECTION 125499 001 2014-08-15 9,474,688 Corning Incorporated (Corning, NY) 2031-10-25 RX search
Biogen Idec Inc PLEGRIDY peginterferon beta-1a INJECTABLE;INJECTION 125499 001 2014-08-15 10,632,112 NOVIRA THERAPEUTICS, INC. (Doylestown, PA) 2034-02-05 RX search
Biogen Idec Inc PLEGRIDY peginterferon beta-1a INJECTABLE;INJECTION 125499 001 2014-08-15 10,350,178 Pathologica LLC (San Francisco, CA) 2033-01-08 RX search
Biogen Idec Inc PLEGRIDY peginterferon beta-1a INJECTABLE;INJECTION 125499 001 2014-08-15 10,213,420 NOVIRA THERAPEUTICS, INC. (Doylestown, PA) 2034-02-05 RX search
Biogen Idec Inc PLEGRIDY peginterferon beta-1a INJECTABLE;INJECTION 125499 001 2014-08-15 10,085,955 Pathologica LLC (San Francisco, CA) 2033-01-08 RX search
Biogen Idec TYSABRI natalizumab VIAL; SINGLE-USE 125104 001 2004-11-23 9,995,752 Children\'s Hospital Medical Center (Cincinnati, OH) Westfaelische Wilhelms-Universitaet Muenster (Muenster, DE) 2033-05-14 RX search
Biogen Idec TYSABRI natalizumab VIAL; SINGLE-USE 125104 001 2004-11-23 9,994,642 Genentech, Inc. (South San Francisco, CA) 2028-09-16 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source
Similar Applicant Names
Companies are sometimes listed under multiple names.
This search can help find similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Mallinckrodt
Moodys
Harvard Business School
Baxter
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.